Literature DB >> 19205850

Selective adhesion of nanoparticles to inflamed tissue in gastric ulcers.

Saad Hassani1, Saad Hasani, Yann Pellequer, Alf Lamprecht.   

Abstract

PURPOSE: Gastrointestinal deposition of nanoparticles was examined after oral administration to mice suffering from an experimental gastric ulcer model. Local drug delivery could reduce side effects and would be a distinct improvement compared to existing therapeutic approaches, e.g. in the local therapy of Helicobacter pylori.
METHODS: A gastric ulcer was induced to Swiss mice by acetic acid injection. Fluorescent polystyrene particles with a nominal size of 50, 200, and 750 nm were administered orally for 3 or 5 days and particle adhesion in the gastrointestinal tract analyzed.
RESULTS: In the ulcerated regions, an enhanced particle adhesion was observed compared to healthy controls. A size dependency of the deposition was found which further increased with a prolonged treatment period. For 750 nm particles only fair adhesion was observed (control, 2.0 +/- 1.4%; ulcer, 4.5 +/- 0.7% of daily administered particle mass), while already 200 nm particles showed higher binding (control, 2.9 +/- 1.3%; ulcer, 7.8 +/- 1.2%). Highest relative adhesion was found for 50 nm particles (control, 2.8 +/- 1.3%; ulcer, 10.0 +/- 1.5%). The targeting index of gastric ulcer versus healthy control was nearly constant around 2 after 3 days treatment, but increased distinctly for smaller particles after 5 days.
CONCLUSIONS: The use of sub-micron sized carriers holds promise for the targeted delivery of drugs to the ulcerated mucosal areas in the stomach.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205850     DOI: 10.1007/s11095-009-9834-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Migration of adhesive and nonadhesive particles in the rat intestine under altered mucus secretion conditions.

Authors:  B Tirosh; A Rubinstein
Journal:  J Pharm Sci       Date:  1998-04       Impact factor: 3.534

2.  Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract.

Authors:  S Sakuma; R Sudo; N Suzuki; H Kikuchi; M Akashi; M Hayashi
Journal:  Int J Pharm       Date:  1999-01-25       Impact factor: 5.875

3.  Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model.

Authors:  R B Umamaheshwari; Suman Ramteke; Narendra Kumar Jain
Journal:  AAPS PharmSciTech       Date:  2004-04-07       Impact factor: 3.246

4.  Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats.

Authors:  Alf Lamprecht; Hiromitsu Yamamoto; Hirofumi Takeuchi; Yoshiaki Kawashima
Journal:  J Pharmacol Exp Ther       Date:  2005-06-24       Impact factor: 4.030

Review 5.  An overview of acetic acid ulcer models--the history and state of the art of peptic ulcer research.

Authors:  Susumu Okabe; Kikuko Amagase
Journal:  Biol Pharm Bull       Date:  2005-08       Impact factor: 2.233

6.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

7.  Mechanisms of action of sucralfate.

Authors:  R Nagashima
Journal:  J Clin Gastroenterol       Date:  1981       Impact factor: 3.062

8.  The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis.

Authors:  Brice Moulari; David Pertuit; Yann Pellequer; Alf Lamprecht
Journal:  Biomaterials       Date:  2008-09-13       Impact factor: 12.479

Review 9.  Helicobacter pylori and gastric carcinogenesis.

Authors:  P Correa
Journal:  Am J Surg Pathol       Date:  1995       Impact factor: 6.394

10.  Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency.

Authors:  P Jani; G W Halbert; J Langridge; A T Florence
Journal:  J Pharm Pharmacol       Date:  1990-12       Impact factor: 3.765

View more
  10 in total

1.  IBD: selective nanoparticle adhesion can enhance colitis therapy.

Authors:  Alf Lamprecht
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06       Impact factor: 46.802

Review 2.  Nanomedicine in GI.

Authors:  Hamed Laroui; David S Wilson; Guillaume Dalmasso; Khalid Salaita; Niren Murthy; Shanthi V Sitaraman; Didier Merlin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-09       Impact factor: 4.052

Review 3.  Nanomedicines in gastroenterology and hepatology.

Authors:  Alf Lamprecht
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-10       Impact factor: 46.802

Review 4.  Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.

Authors:  Wiebke Ulbrich; Alf Lamprecht
Journal:  J R Soc Interface       Date:  2009-11-25       Impact factor: 4.118

5.  Novel lansoprazole-loaded nanoparticles for the treatment of gastric acid secretion-related ulcers: in vitro and in vivo pharmacokinetic pharmacodynamic evaluation.

Authors:  Milind Alai; Wen Jen Lin
Journal:  AAPS J       Date:  2014-02-12       Impact factor: 4.009

6.  Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations.

Authors:  Milind Alai; Wen Jen Lin
Journal:  Int J Nanomedicine       Date:  2015-06-18

7.  Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation.

Authors:  Marlene A Lopes; Bárbara Abrahim-Vieira; Claudia Oliveira; Pedro Fonte; Alessandra M T Souza; Tammy Lira; Joana A D Sequeira; Carlos R Rodrigues; Lúcio M Cabral; Bruno Sarmento; Raquel Seiça; Francisco Veiga; António J Ribeiro
Journal:  Int J Nanomedicine       Date:  2015-09-18

8.  Mucoadhesive microparticles for gastroretentive delivery: preparation, biodistribution and targeting evaluation.

Authors:  Jing-Yi Hou; Li-Na Gao; Fan-Yun Meng; Yuan-Lu Cui
Journal:  Mar Drugs       Date:  2014-12-01       Impact factor: 5.118

9.  Delivering amoxicillin at the infection site - a rational design through lipid nanoparticles.

Authors:  Daniela Lopes-de-Campos; Rita M Pinto; Sofia A Costa Lima; Tiago Santos; Bruno Sarmento; Cláudia Nunes; Salette Reis
Journal:  Int J Nanomedicine       Date:  2019-04-23

10.  Ongoing inflammation enhances the toxicity of engineered nanomaterials: Application of an in vitro co-culture model of the healthy and inflamed intestine.

Authors:  Angela A M Kämpfer; Patricia Urbán; Rita La Spina; Isaac Ojea Jiménez; Nilesh Kanase; Vicki Stone; Agnieszka Kinsner-Ovaskainen
Journal:  Toxicol In Vitro       Date:  2019-11-21       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.